{
    "nctId": "NCT00245869",
    "briefTitle": "Ultrasound and Chemotherapy of Breast Cancer: Relationship Between Early Vascular Changes of the Tumor and Late Tumoral Response",
    "officialTitle": "Contrast-Enhanced Ultrasound and Neoadjuvant Chemotherapy of Breast Cancer: Relationship Between Early Vascular Changes of the Tumor and Late Tumoral Response",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "From contrast-enhanced ultrasound: Enhancement parameters derived from time-intensity curves",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast tumor (size equal to or greater than 3 cm.). Patients with diagnosis of benign breast tumor based on biopsy will be excluded from the study after the first ultrasound examination.\n* Neoadjuvant chemotherapy is programmed when an epithelial carcinoma is diagnosed by histology.\n* Performance status = 0, 1 or 2\n* No previous surgery or local radiotherapy\n\nExclusion Criteria:\n\n* Psychiatric disorders\n* Vital threat due to other disease\n* Vital prognosis \\< 3 months\n* Biopsy of the lesion performed within 1 month before the ultrasonography\n* Patient known to have a coronary syndrome\n* Unstable angina and myocardial infarction\n* Acute cardiac failure, Class III/IV cardiac failure\n* Several arrhythmias\n* Acute endocarditis\n* Prosthetic valves",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}